DenovAI Biotech
DenovAI Biotech is at the forefront of a protein design revolution, leveraging artificial intelligence and computational molecular biophysics to design proteins from scratch. Their technology platforms focus on creating next-generation therapeutics, including high-affinity antibodies and small protein binders, tailored for specific targets. The company aims to accelerate the discovery process from months to days and broaden therapeutic applications for various diseases. DenovAI Biotech is a portfolio company of AION Labs, an alliance of major pharmaceutical companies and tech providers.
DenovAI Biotech
DenovAI Biotech is at the forefront of a protein design revolution, leveraging artificial intelligence and computational molecular biophysics to design proteins from scratch. Their technology platforms focus on creating next-generation therapeutics, including high-affinity antibodies and small protein binders, tailored for specific targets. The company aims to accelerate the discovery process from months to days and broaden therapeutic applications for various diseases. DenovAI Biotech is a portfolio company of AION Labs, an alliance of major pharmaceutical companies and tech providers.